Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Multidisciplinary Cutaneous Lymphoma

INSTITUTE
UH Seidman Cancer Center

DIRECTOR
Kevin D. Cooper, MD 216-844-8200

CO-DIRECTOR
Kord Honda, MD 216-844-8200

KEY CONTACT
Susan Stebal 216-844-3634

APPOINTMENT LINE
216-844-8200, select 1

Conditions Treated

Cutaneous T-cell lymphomas
Cutaneous B-cell lymphomas
Sezary leukemia
Sezary syndrome
Mycosis fungoides
Pseudolymphoma
Lymphoproliferative diseases of the skin

Therapies and Services

Full spectrum of skin directed therapies, systemic therapies and radiation therapies
Distinguishing Features
These programs, developed collaboratively by the Department of Dermatology and UH Seidman Cancer Center, provide the type of cross-specialty care and care-path development that is required for the optimum patient benefit and efficient delivery of services for patients with high-risk cancers occurring in the skin.
Weekly tumor boards staffed by physicians of different specialties, nurses and program staff allow rapid decision making based on pathologic, clinical and lab data, and consensus diagnostic and management recommendations.
Cutaneous dermatologic oncology, radiation oncology, dermatopathology, surgical oncology and medical oncology are included.